LI JING,LI JING,ZHENG YONG,ZHENG YONG,CHEN ZHISHENG,CHEN ZHISHENG
申请号：
CL2018000370
公开号：
CL2018000370A1
申请日:
2018.02.09
申请国别(地区):
CL
年份:
2018
代理人:
摘要：
The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which can block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.
